IL6 and major depressive disorder: Third, MDD has been repeatedly associated with chronic increases in inflammatory biomarkers (especially tumor necrosis factor [TNF], interleukin-6 [IL-6] and IL-1-beta) [13, 14], and anti-inflammatory agents have been reported to reduce depressive symptoms in patients with increased inflammation [9].